Market Grapples With Crisis<br />By Rev Shark<br />RealMoney.com Contributor<br />3/17/2008 8:25 AM EDT <br /><br />The easiest period in a crisis situation is actually the battle itself. The most difficult is the period of indecision -- whether to fight or run away. And the most dangerous period is the aftermath. It is then, with all his resources spent and his guard down, that an individual must watch out for dulled reactions and faulty judgment. -- Richard M. Nixon <br /><br />The market is grappling with the stunning collapse of Bear Stearns (BSC) this morning. What is so unnerving about this situation isn't that a major brokerage is having problems but that the market did such an amazingly poor job of anticipating what was happening. A week ago BSC was trading over $70, and today it is essentially worthless. If the market is so totally incapable of valuing BSC how can we trust it to value anything else. <br /><br />This is clearly a major financial crisis for the U.S. economy that will have widespread and long-lasting ramifications. We need to proceed with extreme care at this juncture to protect ourselves. As I've been saying for some time it is far more important in a bad market to protect our capital than try to find profits when conditions are so uncooperative. Ultimately some big money will be made in this crisis as the situation plays out but much money will also be lost by those who act rashly and prematurely. <br /><br />The big problem for the market at this point is that we still do not have any clarity as to the extent of the problem. Normally a major crisis like the collapse of Bear Stearns can help the market bottom as it serves to purge some of the poison in the system. While that is true to some extent in this case we still really don't know how far reaching these problems are. If Bear can go from $70 to $2 so quickly why can't something else? <br /><br />A further problem we are facing is that the short-term moves by the Fed to shore up the problems may do nothing but delay some of the problems we are facing. Already we can see the dollar spiraling into the abyss and fears of inflation are growing quickly as the market is flooding by attempts to create liquidity and keep financial systems from seizing up. <br /><br />The hope of the bulls at this point is that this crisis will create some panic and give us a washout that results in a tradable low. Certainly the mood is sour enough that conditions are becoming good for a bounce particularly if governmental officials are successful in restoring some calm. <br /><br />However, the biggest danger will come once things settle down, and we find that there aren't many catalysts for the market to rebound. We are likely to be plagued by the fear of the unknown even as we digest that Bear Stearns news today. <br /><br />My advice remains what it has been for a while now. Stay patient, respect the fact that we are in a downtrend and don't try to guess when the bottom will occur. If you protect your precious capital now you will have the ability to profit greatly in the future. There is going to be a lot of chaos in the next few days. If you are a very short term trader there may be some opportunities but if you are a longer term investor it will still be too early to take any significant action. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: HNR +3.8%, RAMR +3.5%, PMI +1.8%... M&A news: DMX +22.1% (receives tender offer to be acquired for $5.40/share by Walgreen's), BLOG +14.4% (BMC Software to Purchase BladeLogic for $28/share in cash), JPM +1.5% (to acquire BSC for $2/share, also ratings affirmed by Moody's and S&P)... Select gold stocks showing strength on higher spot prices: AUY +4.2%, GFI +2.6%, KGC +2.5%, GLD +2.3%, ABX +1.1%... Other news: CRME +29.8% (announces positive interim Ph. 2b results for oral vernakalant and engages Merrill Lynch as strategic advisor), TWTI +6.5% (Third Wave's InPlex CF Molecular Test receives FDA clearance), TUP +1.3% (Cramer makes positive comments on MadMoney)... Analyst upgrades: NAT +1.9% (upgraded to Neutral at JPMorgan).<br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: TPX -11.0%, CNO -6.6%, BJGP -4.5%, ITW -4.4%, PGNX -3.8%, VQ -2.4%, SUI -2.1%, GBL -1.5%... M&A news: BSC -89.1% (to be bought by JP Morgan for $2/share in stock-swap)... Financial stocks are under heavy pressure after fire sale at BSC: LEH -31.4% (also downgraded to Neutral at UBS), WM -16.1%, MER -15.2%, C -15.0%, NCC -14.8%, CIT -14.6%, ABK -12.4%, CFC -10.7%, WB -10.5%, MBI -10.4%, UBS -10.4% (to consider 8,000 layoffs - NY Times), FNM -10.1%, IMB -9.4%, BCS -9.2%, MS -9.0%, GS -8.8% (also downgraded to Neutral at UBS), STT -8.4% (also downgraded to Neutral at UBS), RBS -8.1%, FRE -7.9%, COF -7.9%, CS -6.0%, AIG -5.8%, BAC -5.4%, DB -5.4%, ETFC -5.0%, WFC -4.9%, RF -3.7%, HBC -3.7%, BK -3.5% (also downgraded to Neutral at UBS)... Other news: SI -17.4% (outlook dims as several projects struggle - WSJ), CVTX -6.3% (announces they have not received action on the NDA, for regadenoson, from the FDA), ASTI -2.4% (files an $80 mln common stock shelf offering in an S-3), ADBE -1.7% (Hearing tier-1 firm cuts EPS ests for ADBE, saying macro outlook has deteriorated)... Analyst downgrades: MBLX -6.0% (downgraded to Hold at Jefferies), MRO -5.5% (downgraded to Neutral at tier 1 firm), AMTD -5.5% (downgraded to Neutral at UBS), CX -4.1% (downgraded to Neutral from Outperform at Credit Suisse), DHT -2.7% (downgraded to Underweight at JPMorgan), PT -2.4% (downgraded to Underweight at JPMorgan), COH -1.5% (downgraded to Hold at Citigroup).